From: The Lebanese left ventricular assist device experience, a success story despite the odds
| Mean age (years) | 49.8 ± 12.7 |
|---|---|
| Female | (25) 32% |
| Diabetes | (32) 41% |
| Hypertension | (32) 41% |
| Dyslipidemia | (34) 44% |
| Smoking | (25) 32% |
| Body mass index (Kg/m2) | 24.9 ± 3.1 |
| Previous CABG | (11) 14% |
| Creatinine | 1.4 ± 0.4 |
| ICD/CRTD | (65) 83% |
| Mean LVEF (%) | 18 ± 2.8 |
| LVEDD (mm) | 73 ± 5.1 |
| TAPSE (mm) | 14.9 ± 3.9 |
| CVP (mmHg) | 13.7 ± 4.0 |
| Cardiac index (l/mn/m2) | 1.7 ± 0.3 |
| INTERMACS | 2.0 ± 0.4 |
| BTT | (41) 53% |
| DT | (33) 42% |
| BTR | (4) 5% |
| ECMO | (9) 11.6% |
| IABP | (4) 5% |